chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 3 hours, I had aches and pains and fatigue that lasted 3 1/2 weeks. A week later, I came down with bronchitis. I was on antibiotics for 7 days. The bronchitis got better but the pains and fatigue did not. That lasted another 2 1/2 weeks.  I was sleeping 11-12 hours a day because of the fatigue. I felt better in 3 1/2 weeks and three days later received the second shot.
Information has been received from a registered nurse concerning a now 40 year old daughter who was vaccinated with ATTENUVAX as a child and experienced a reaction (not specified). It was unknown if the patient sought medical attention. At the time of reporting, the patient's status was unknown. This is one of several reports received from the same source. Additional information has been requested.
General tiredness, sore arm; General tiredness, sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Oct2022 at 12:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 34 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: Other medical history: No. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (PRIMARY SERIES COMPLETED, UNKNOWN MANUFACTURE), for Covid-19 immunization; Bnt162b2 (Dose 3, other vaccine same date vaccine location= Left arm), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 19Oct2022 at 06:00, outcome "recovering" and all described as "General tiredness, sore arm". Therapeutic measures were not taken as a result of fatigue, pain in extremity.  Additional information: Facility type vaccine workplace clinic. No other vaccine in four weeks. Adverse event start time was 06:00 AM. No any treatment for AE. Covid was not prior vaccination. Covid was not tested post vaccination. No Known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
99.9 FEVER  3 DAYS ACHY ALL OVER HEADACHE  NAUSEA SEVERE PAIN IN EAR LIKE ICE PICK GOING THROUGH IT (BOTH) SIMILAR PAIN IN RIGHT LEG STARING AT THIGH GOING DOWN TO ANKLE I HAVE ONLY BEEN THIS SICK ONCE BEFORE 5 YEARS AGO.
anemia, immature granulocytes, increased neutrophils, increased lymphocytes  1/5/22 - H/H - 11.2/37   WBC 11.2 - increased neutrophils, increased lymphocytes  1 immature granulocyte  1/7/22 repeat H/H 11.6/38  WBC 12.0, increased neutrophils + monocytes 1 immature granulocyte  HIV - negative, abnormal CD3 - 258 increased, CD4 2320 increased CD8 288, CD4/8 ratio: 8.06 increased  flow cytometry negative
Information has been received from a licensed practical nurse (LPN) concerning a 9 week old female with gastric reflux and no allergies who on 14-SEP-2006 was vaccinated PO with a 2.0ml dose of  rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine); (lot #655082/0779F). Concomitant vaccination administered on that same day included a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar). Hib conj vaccine (OMPC) (manufacturer unknown). Other concomitant therapy included ranitidine HCL (Zantac). The LPN reported that on 14-SEPY-2006 the patient regurgitated the dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine). Unspecified medical treatment was sought but no laboratory/diagnostic tests were performed. On that same day the patient recovered. Additional information has been requested.
On 9/3/00, the pt developed stuffiness and slight nasal congestion. Next day, she experienced a fever of 102. On 9/5/00, the pt had a croupy cough and clear nasal discharge.
on  june 29,2002 my 20 year old daughter died of a brain aneurysm. it had no symptoms and was a complete surprise.
Received a Shingrix shot 10 days ago and now I have shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2021, the patient received Shingrix. On an unknown date, 10 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: Age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient received a Shingrix shot 10 days before the reporting date and now the patient had shingles.
1st Covid vaccine on 2/19/2021, patient had syncope in the parking lot, unbale to speak, confused taken to the hospital by ambulance.
Doses were administered past the 30-day beyond use date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered past the 30-day beyond use date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered past the 30-day beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were administered past the 30-day beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter stated that the date the vial was initially stored in the refrigerator was on 04-Aug-2021. The number of doses/ vials were unknown. It was confirmed there was no temperature excursion.  No concomitant medication reported. No treatment medication reported.
breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding) in a  patient of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 012A21A) , while the mother received the product for COVID-19 vaccination.     Concomitant product exposures included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 25-Feb-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The mother's last menstrual period was on 26-Jun-2020 and the estimated date of delivery was 15-Mar-2021. On an unknown date, the patient was diagnosed with EXPOSURE VIA BREAST MILK (breastfeeding). The delivery occurred on an unknown date, which was reported as Full-term. For neonate 1, The outcome was reported as Delivered NOS. At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding) had resolved.            Treatment medication was not provided   This case was linked to MOD-2021-065319 (Patient Link).
Case PHEH2016US023453 is an initial spontaneous report received from nurse on 13 Sep 2016. This case refers to 59 year old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN (batch number: 1515701, expiry date: not reported) at a dose of 0.5 ml intramuscular into left arm on 01 Dec 2015. It was reported that, the patient received FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion and it was administered to unknown number of patients. No adverse event was reported following this medication error.
listed side effects / joint pain; stiffness; This case was reported by a consumer and described the occurrence of joint pain in a 61-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had it twice before.). Previously administered products included shingrix with an associated reaction of adverse event (1st dose received on an unknown date).  On 1st February 2021, the patient received the 2nd dose of Shingrix. In February 2021, less than a week after receiving Shingrix, the patient experienced joint pain and stiffness. On an unknown date, the outcome of the joint pain and stiffness were not recovered/not resolved.   It was unknown if the reporter considered the joint pain and stiffness to be related to Shingrix.  Additional details were provided as follows:  The reporter consent to follow up. After receiving 2nd dose of Shingrix, the patient experienced joint pain and stiffness. The patient was saying hope was the side effects from the second shot would be less difficult, but that has not been experience. The patient was in good health, and never had a significant reaction to a vaccine before and get that it's unpredictable but feel like his/her doctor minimized the potential saying some patients feel a little peeked the next day. The patient believed in vaccinations, but if asked by friends and acquaintances, will provide an honest and unflattering appraisal of his/her experience and understand it's immune response working, but would suggest research to discover a way to mitigate side effects. Otherwise, there will be reluctance from the public to acquire this vaccine as its reputation spreads. This case linked with US2021AMR054924, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR054924:same reporter
Temp. of 103 deg F. from 09/16/2001 to office visit of 09/19/2001. Had varivax and mmr vaccinations on 09/07/2001
Patient presented on 11/5/05 with c/o pain with swallowing and a swollen node on the L side. Symptoms present times 4-5 days. S/P tooth extraction on 2 wisdom teeth 2 days prior. Smallpox vaccine given 10/14/05. MD diagnosed as marked lymphadenopathy left cervical region. secondary to small pox vaccination. Augmentin 500mg bid ordered. Quarters times 24 hours, push fluids and return in 1 week.
On 4/15, I had a telehealth visit with a doctor to see what I can do for the pain and lymph nodes. I was told to take ibuprofen, but the pain was getting worse. On 4/16, I called nurse line to see what more I could do. They suggest I be seen in person. I saw a doctor who said this was a normal side effect of the vaccine. The lump had resolved by the afternoon. I was prescribed a higher dose of NSAID. He said the regular bottle was not strong enough. I was also prescribed 15mg meloxicam 1x.day for inflammation. I took this for 3-4 days and things resolved. I started having pretty severe abdominal on 6/10 on my left side. I called the doctors. While speaking with the nurse the pain resolved. The deemed it unnecessary to be seen by a doctor immediately so I scheduled an appointment with my OB/Gyn on 6/21. I was sent for an ultrasound a few days later where it was determined on my left side, I had a large, complicated cyst on my ovaries. I was seen again about 8 weeks later on 8/30 I had a follow up ultrasound that showed the left complicated cyst had resolved but the right side has cysts remaining. I was diagnosed with poly cystic ovarian syndrome which I did not have before. I also had an IUD placed in but the symptoms occurred prior to getting this.
VACCINE DOSING ERROR: MMR AND MMRV BOTH ADMINISTERED TO PATIENT 04-27-2020
Pain in left arm, redness, warmth and swelling at and below injection site, headache
Patient had a partial complex seizure that started 90 minutes after administration. She was unresponsive for 5 minutes followed by her most severe postictal state ever. She was completely confused, combative: hitting, kicking, screaming.
short of breath; positive for COVID-19; back pain; cough; fatigue; fever of 102F; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (positive for COVID-19), BACK PAIN (back pain), COUGH (cough), DYSPNOEA (short of breath) and FATIGUE (fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced BACK PAIN (back pain), COUGH (cough), FATIGUE (fatigue) and PYREXIA (fever of 102F). On 19-Feb-2021, the patient experienced COVID-19 (positive for COVID-19). On an unknown date, the patient experienced DYSPNOEA (short of breath). At the time of the report, COVID-19 (positive for COVID-19), BACK PAIN (back pain), FATIGUE (fatigue) and PYREXIA (fever of 102F) outcome was unknown and COUGH (cough) and DYSPNOEA (short of breath) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient was treated with hycodan cough syrup, a Z-pack, aspirin, ascorbic acid, melatonin, and albuterol.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2021: Additional initial document received.
Began feeling like she "had the flu" with muscle aches and joints the evening after the vaccine (7/17) and continues to feel badly. On 7/19/18 the site of injection began is noted to be red, swollen, hard, hot and very tender to the touch. The area measures 9.8x9.3cm. Physician visited and wrote orders for ice to the area, PRN BENADRYL, TYLENOL and oral antibiotics.
pt stated is subject to anxiety attacks felt tingling in fingertips; pt took medication for anxiety attacks;
Site: Itching at Injection Site-Mild, Additional Details: Patient had a site reaction and was given 20 ml benadryl which resolved the issue within 30 minutes
Lymphadenopathy within the left axillae. Redness, mild pain and tenderness, and pruritus at the site of injection.
Chills; Fever; Left Arm Hurts; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 79/11M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 03-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts).   The patient was treated with PARACETAMOL (TYLENOL) on 10-Feb-2021 for Fever and Pain in arm, at an unspecified dose and frequency.   At the time of the report, CHILLS (Chills), PYREXIA (Fever) and VACCINATION SITE PAIN (Left Arm Hurts) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 101.6 (High) Patient has Fever of 101.6 F.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
About noon I noticed aches, including a bad headache, a general unwell feeling, and a sore throat. By that evening I had a fever of 101. I used an at home COVID-19 test, positive. I developed a cough at that time as well. I was unable to focus on anything. 5/5/2023 Televisit with doctor who prescribed PAXLOVID and to treat symptomatically. I did notice the strong metallic taste while taking PAXLOVID. On 5/8 I tested negative. After finishing the 5-day course of PAXLOVID, 5/11, the symptoms came back and I began to test positive again. On day 5/16, I felt better. Day 5/17 I tested negative, but symptoms got worse. On day 5/19, I tested positive again. At time of report, cough is slightly better, but symptoms are ongoing.
Pt developed a DVT which resulted in a PE. Pt was treated with Eliquis. He is now stable, he is following with Pulmonology and Hematology.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 5/16/2023 THORACIC AORTIC ANEURYSM, UNSPECIFIED PART J96.00 ACUTE RESPIRATORY FAILURE 6/6/2023 THORACIC AORTIC ANEURYSM, UNSPECIFIED PART J96.10 CHRONIC RESPIRATORY FAILURE 5/26/2023 THORACIC AORTIC ANEURYSM, UNSPECIFIED PART R57.0 CARDIOGENIC SHOCK 5/16/2023 THORACIC AORTIC ANEURYSM, UNSPECIFIED PART D68.9 COAGULOPATHY, UNSPECIFIED TYPE 5/16/2023 CHRONIC RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 6/6/2023 CHRONIC RESPIRATORY FAILURE J96.10 CHRONIC RESPIRATORY FAILURE 5/26/2023 CHRONIC RESPIRATORY FAILURE R57.0 CARDIOGENIC SHOCK 5/16/2023 CHRONIC RESPIRATORY FAILURE D68.9 COAGULOPATHY, UNSPECIFIED TYPE 5/16/2023 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 6/6/2023 ACUTE RESPIRATORY FAILURE J96.10 CHRONIC RESPIRATORY FAILURE 5/26/2023 ACUTE RESPIRATORY FAILURE R57.0 CARDIOGENIC SHOCK 5/16/2023 ACUTE RESPIRATORY FAILURE D68.9 COAGULOPATHY, UNSPECIFIED TYPE 5/16/2023 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 6/6/2023 ACUTE RESPIRATORY FAILURE J96.10 CHRONIC RESPIRATORY FAILURE 5/26/2023 ACUTE RESPIRATORY FAILURE R57.0 CARDIOGENIC SHOCK 5/16/2023 ACUTE RESPIRATORY FAILURE D68.9 COAGULOPATHY, UNSPECIFIED TYPE 5/16/2023 RESPIRATOR DEPENDENCE J96.00 ACUTE RESPIRATORY FAILURE 6/6/2023 RESPIRATOR DEPENDENCE J96.10 CHRONIC RESPIRATORY FAILURE 5/26/2023 RESPIRATOR DEPENDENCE R57.0 CARDIOGENIC SHOCK 5/16/2023 RESPIRATOR DEPENDENCE
8MAY97 PM fussy, mild temp elevation;9MAY97 1215AM mom awoke to  observe febrile sz (tonic, clonic movements) lasted 10min (per mom);called 911;amb to ER -no tx upon arrival;
No adverse event. Shot was administered past the recommended 6 week window after first shot. Patient received first shot on 4/20/21 at different location.
1/2 dollar size firm lump at site of anthrax vaccine #2 x5 days.  Started with lump, expanding area of redness and mild itching.  Redness has completely disapeared.  Lump is visable and palpable (firm to touch).  No systemic symptoms.
This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021), ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included LISINOPRIL, HCTZ, FENOFIBRATE, VITAMIN and MAGNESIUM for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021). On 06-Mar-2021, the patient experienced ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (fatigue). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 23Jan2021 and 2nd dose on 05 Mar 2021) outcome was unknown and ILLNESS (felt sick), HEADACHE (headache), ARTHRALGIA (joint pain), MYALGIA (muscle pain), NAUSEA (nausea) and FATIGUE (fatigue) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications include overt the counter cold pills,allergy pill and advised to take Tylenol by doctor. Action taken with mRNA-1273 in response to the event was not applicable.
since March 10 I have had a tremor unsterady   when going down steps i feel like im going to fall
Patient received vaccine at approx 9am and around 2:15 pm she started developing itchy eyes, swelling of eyelids L>R, redness of cheeks. No shortness of breath, no difficulty swallowing, no hoarseness of voice.
tested positive; tested positive after the first dose; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable consumer reported for a female patient (Mom). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection),via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization.The patient's medical history and concomitant medications were not reported.On an unspecified date, the patient tested positive after the first dose. The reporter mentioned that her mom was due to get her second dose today, but she wants to know if she can reschedule it. The reporter has already spoken with doctor and doctor told her mother that she will be tested for Covid-19 and that if the test is negative, she should wait another week to receive the second dose of the vaccine, also this week she completes her 14-day quarantine. The outcome of events was unknown.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
About 9 minutes after receiving the vaccine the fingers on  my left hand started going numb. I started shaking and breaking out in hives. The nurse took my blood pressure  and it was elevated. They quickly walked me down to the emergency department where they started an IV.  Medications I was given was diphenhydrAMINE, famotidine, MethyIPREDNISolone sod succinate 0.9% NaCI (NS), acetaminophen.  Cardiac monitor and saline lock maintenance.  Image testing done was EKG.  I got to the emergency department at 11:45 am and was discharged at 3:49 pm.
Am after shots 101.0 temp, hives on L deltoid only (warm, raised, to elbow) lasting 3 days. Patient also took BENADRYL. Did not seek medical attention, fully recovered.
a 98 year old woman where I live got the shingles after getting the vaccine / SUSPECTED VACCINATION FAILURE; got the shingles; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 98-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  The relationship of the reporter to the patient was unclear. The age at vaccination was not reported. The reporter did not know which year or which Shingles vaccine the patient received. The reporter stated that, a 98 years old woman where he/she live got the shingles after getting the vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The reporter did not consent to follow-up. This case had been linked with US2021151558, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021151558:same reporter